Journal News

JLR: What controls cholesterol biosynthesis?

Laurel Oldach
Sept. 1, 2019

Homeostasis is an important biochemical principle. The pace of a biosynthetic pathway often is controlled by feedback from pathway products, adjusting the system to prevent excessive accumulation of its products.

Pathway diagramA pathway diagram shows two parallel routes from mevalonate to cholesterol.Bao-Liang Song

Cholesterol biosynthesis is one example. Researchers know it is regulated by metabolic intermediates but until now have disagreed about which intermediates do the work. In the Journal of Lipid Research, Liang Chen and colleagues at Wuhan University and the Chinese Academy of Sciences report that several metabolites can affect the activity of two cholesterol biosynthesis enzymes. The study gives new insight into how cholesterol biosynthesis is regulated.

Researchers knew that an intermediate product of the biosynthetic pathway could inhibit each of two control points: HMG-CoA reductase, or HMGCR, which synthesizes a key cholesterol precursor called mevalonate, and sterol responsive element-binding protein, or SREBP, a transcription factor that affects many cholesterol synthesis enzymes.

Data suggested that lanosterol, the first intermediate in the pathway that is cyclic instead of linear, was the key regulator, but the researchers knew that a slightly modified version of lanosterol might be more important. The question is complicated because the cholesterol biosynthesis pathway bifurcates after lanosterol is formed.

In lanosterol or any of its downstream products, a double bond in the molecule’s alkyl tail can be reduced, and the reduced molecules proceed through the same steps to be turned into cholesterol (see figure). So which intermediate cholesterol metabolite exerts the most control over the overall biosynthetic pathway?

That is a technically difficult problem. It is hard to induce accumulation of specific intermediates, because no effective enzyme inhibitors exist for specific steps in sterol synthesis and cells are unlikely to take up exogenously added pathway intermediates.

Chen and colleagues worked around these difficulties by generating a cell line better equipped to absorb mevalonate, a key intermediate produced by HMGCR. In these cells, intermediates can accumulate even if HMGCR activity is blocked. When these cells are provided with mevalonate, they scale up cholesterol production, triggering homeostatic degradation of HMGCR and blocks SREBP activation.

The team then systematically knocked out cholesterol biosynthesis enzymes using CRISPR, forcing traffic to back up immediately upstream of whichever conversion step had been blocked. Using lipidomic analysis of sterol extracts from each knockout cell line, they assessed the impact of loss of each enzyme and accumulation of its substrate, identifying key metabolites that impacted levels of HMGCR and SREBP.

The researchers showed that lanosterol down-regulated HMGCR but not SREBP, confirming that lanosterol and not its reduced relative is the key regulator. They also found that other sterol intermediates with reduced double bonds inhibited both HMGCR and SREBP. The authors say that molecules resembling these endogenous regulators could be a new way to control cholesterol levels.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Related articles

From the journals: JLR
Brian O'Flynn
From the journals: JLR
Vaishnavi Muralikrishnan
From the journals: JLR
Lisa Learman & Laurel Oldach
From the journals: JLR
Himanshi Bhatia

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Meet Stephanie Moon
Observance

Meet Stephanie Moon

Aug. 2, 2021

She studies messenger RNA regulation at the University of Michigan in Ann Arbor.

Researchers find a cell surface decorated with sugar-coated RNAs
News

Researchers find a cell surface decorated with sugar-coated RNAs

Aug. 1, 2021

Finding not just glycoproteins and glycolipids but also glycoRNA means “now there are three hands, and we don’t know what that third hand is doing.”

Unraveling the mysterious mutations that make delta the most transmissible COVID virus yet
News

Unraveling the mysterious mutations that make delta the most transmissible COVID virus yet

July 31, 2021

As of this week, the delta variant had caused at least 92% of the new infections in the United States, according to a research firm in Switzerland.

Cats communicate with the help of bacteria living in their butts
News

Cats communicate with the help of bacteria living in their butts

July 31, 2021

KittyBiome researchers want to study the cat microbiome to improve health and understand scent-based communication.

From the journals: JLR
Journal News

From the journals: JLR

July 29, 2021

Reversing alcoholism’s effects on lipid droplets. How HDL cholesterol might reduce COVID-19 risk. Shining light on the cholesterol–GPCR relationship. Read about recent papers on these topics in the Journal of Lipid Research.

Starved to death: Can dietary methionine combat cancer?
Journal News

Starved to death: Can dietary methionine combat cancer?

July 27, 2021

Scientists draw a connection between this essential amino acid and cancer lipid metabolism.